INVOKANA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
INVOKANA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
113884006IP
Prescription Type
Medicamento Sujeto A Prescripción Médica
Authorization Date
Sep 29, 2023
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number113884006IP
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
CANAGLIFLOZINAActive
Quantity: 300 mg
Name: CANAGLIFLOZINA
ATC CLASSIFICATION (3)
A10B
A10BK
A10BK02